Moreover, we confirmed the over-expression and hyper-phosphorylation of PLK1 and FOXM1 in the MNCs from CML patients at diagnosis compared to the healthy donor pool (Fig. 3) [8]. The gene discussed is PLK1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.